Literature DB >> 19296948

Immunoreactivity of progesterone receptor isoform B, nuclear factor kappaB, and IkappaBalpha in adenomyosis.

Jichan Nie1, Yuan Lu, Xishi Liu, Sun-Wei Guo.   

Abstract

Compared with normal endometrium, progesterone receptor isoform B (PR-B) and IkappaBalpha immunoreactivity were statistically significantly reduced in ectopic as well as eutopic endometrium from women with adenomyosis while nuclear p65, p50, and p52 immunoreactivity were statistically significantly increased in ectopic and eutopic endometrium. Nuclear p65 immunoreactivity was positively associated with heavier menses, and decreased PR-B and increased nuclear p65 immunoreactivity in ectopic endometrium were statistically significantly associated with the severity of dysmenorrhea in women with adenomyosis.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19296948     DOI： 10.1016/j.fertnstert.2009.01.084

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  15 in total

1.  Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis.

Authors:  Christopher N Herndon; Lusine Aghajanova; Shaina Balayan; David Erikson; Fatima Barragan; Gabriel Goldfien; Kim Chi Vo; Shannon Hawkins; Linda C Giudice
Journal:  Reprod Sci       Date:  2016-05-27       Impact factor: 3.060

2.  Transcriptome analysis of eutopic endometrial stromal cells in women with adenomyosis by RNA-sequencing.

Authors:  Lin Gan; Yongrong Li; Yan Chen; Meihua Huang; Jian Cao; Meiling Cao; Zhihui Wang; Guiping Wan; Tao Gui
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Epigallocatechin-3-gallate reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice induced with adenomyosis.

Authors:  Yumei Chen; Bo Zhu; Hongping Zhang; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Sci       Date:  2013-05-23       Impact factor: 3.060

4.  Pathology and Pathogenesis of Adenomyosis.

Authors:  Maria Facadio Antero; Ayse Ayhan; James Segars; Ie-Ming Shih
Journal:  Semin Reprod Med       Date:  2020-10-20       Impact factor: 1.303

5.  Possible Loss of GABAergic Inhibition in Mice With Induced Adenomyosis and Treatment With Epigallocatechin-3-Gallate Attenuates the Loss With Improved Hyperalgesia.

Authors:  Yumei Chen; Bo Zhu; Hongping Zhang; Ding Ding; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Sci       Date:  2014-02-03       Impact factor: 3.060

6.  Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review.

Authors:  Marissa J Harmsen; Caroline F C Wong; Velja Mijatovic; Arjan W Griffioen; Freek Groenman; Wouter J K Hehenkamp; Judith A F Huirne
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

7.  The effect of pycnogenol on patients with dysmenorrhea using low-dose oral contraceptives.

Authors:  Hugo Maia; Clarice Haddad; Julio Casoy
Journal:  Int J Womens Health       Date:  2014-12-11

8.  Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence.

Authors:  Bo Zhu; Yumei Chen; Xiaolu Shen; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Biol Endocrinol       Date:  2016-10-10       Impact factor: 5.211

9.  Increased expression of nuclear factor kappa-B p65 subunit in adenomyosis.

Authors:  Hana Park; Sung-Hoon Kim; Yoo Mi Cho; Hyo Jin Ihm; Young Sang Oh; Seung Hwa Hong; Hee Dong Chae; Chung-Hoon Kim; Byung Moon Kang
Journal:  Obstet Gynecol Sci       Date:  2016-03-16

10.  Immunoreactivity of Plasminogen Activator Inhibitor 1 and Its Correlation with Dysmenorrhea and Lesional Fibrosis in Adenomyosis.

Authors:  Bingxin Yang; Nihao Gu; Shu Shi; Chen Zhang; Lan Chen; Jing Ouyang; Yu Lin; Feng Sun; Hong Xu
Journal:  Reprod Sci       Date:  2021-03-08       Impact factor: 3.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.